Skip to main content

Table 2 Patients’ clinical and demographic characteristics, procedural indications, and medication dosages

From: Sedation-related complications during anesthesiologist-administered sedation for endoscopic retrograde cholangiopancreatography: a prospective study

Male, n (%)128/200 (64)
Mean age ± SD, (years)56.3 ± 15.2
ASA score, n (%)
 I7 (3.5)
 II73 (36.5)
 III119 (59.5)
 IV1 (0.5)
Disorder, n (%)
 Hepatic127/200 (63.5)
 Gastrointestinal31/200 (15.5)
 Postoperative20/200 (10)
 Other disorders22/200 (11)
Procedural indications, n (%)
 Malignant jaundice58/200 (29)
 Stricture after LTX45/200 (22.5)
 Stones/sludge37/200 (18.5)
 Postoperative complications18/200 (9)
 Other reasons42/200 (21)
Medication dosages
 Propofol mean dose ± SD, (mg)287 ± 134
 Propofol mean dosage ± SD, (mg/kg)3.8 ± 1.7
 Remifentanil mean dose ± SD, (μg)135 ± 68
 Remifentanil mean dosage ± SD, (μg/kg)1.8 ± 1.0
  1. ASA I: normal healthy patients, ASA II: patients with mild systemic disease, ASA III: patients with severe systemic disease, ASA IV: patients with severe systemic and life-threatening disease
  2. ASA American Society of Anesthesiologists
  3. LTX Liver transplantation, SD Standard deviation